Riskpilot← Back to searchSign inGet full accessHUSEBYSKOGEN MEDISINSKE SENTER SA
SAActiveOrg 987578424Sørkedalsveien 150A, 0754 OsloGeneral medical practice activities · NACE 8621Est. 20054 employees
Revenue 2025
NOK 5,2M
+14% vs 2024
EBITDA margin
2.4%
+161% vs 2024
Equity ratio
-8.9%
Financial strength
Net profit 2025
NOK 113K
+148% vs 2024
| Revenue | NOK 5,2M | +14% |
| EBITDA | NOK 126K | +161% |
| Net profit | NOK 113K | +148% |
| Total assets | NOK 1M | +94% |
| Equity | NOK -90K | +56% |
| Employees | 4 | — |
Legal name
HUSEBYSKOGEN MEDISINSKE SENTER SA
Org number
987578424
Legal form
Samvirkeforetak
NACE code
8621 · General medical practice activities
Founded
13. april 2005
Share capital
—
Employees
4 (FTE)
VAT registered
No
Audit selected
No
Last report
2025-12-31
Financial year
January – December
Signatory rights
To styremedlemmer i fellesskap.
Company purpose
Drive husebyskogen medisinske senter sa.
Address
Sørkedalsveien 150A, 0754 Oslo
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
| Item | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|
| Revenue | 4 372 | 4 124 | 4 275 | 4 574 | 5 232 |
| Staff expenses | −1 289 | −1 386 | −1 548 | −1 665 | −1 713 |
| EBITDA | 415 | 28 | −196 | −206 | 126 |
| Depreciation & amort. | −3 | −21 | −21 | −17 | −0 |
| EBIT | 411 | 7 | −216 | −223 | 126 |
| Net financials | −7 | −15 | −15 | −13 | −13 |
| Profit before tax | 404 | −9 | −232 | −236 | 113 |
| Tax | 85 | −0 | −0 | −0 | −0 |
| Net profit | 319 | −9 | −232 | −236 | 113 |
| Item | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|
| Total assets | 1 396 | 913 | 1 005 | 519 | 1 006 |
| Equity | 274 | 265 | 33 | −203 | −90 |
| Long-term debt | 0 | 0 | 0 | 0 | 0 |
| Short-term debt | 1 123 | 648 | 972 | 722 | 1 096 |
| Total debt | 1 123 | 648 | 972 | 722 | 1 096 |
EBITDA margin
2.4%
This company
15.8%
Market median
-85% vs market
20212025
Equity ratio
-8.9%
This company
38.2%
Market median
-123% vs market
20212025
Return on equity
11289700.0%
This company
18.4%
Market median
+61356965% vs market
20212025
Net profit margin
2.2%
This company
8.1%
Market median
-73% vs market
20212025
Asset turnover
5.20×
This company
1.12×
Market median
+364% vs market
20212025
Debt / equity
12.20×
This company
0.62×
Market median
-1868% vs market
20212025
- Annual report 2025Filed via Brønnøysundsregistrene · Period 2025-01-01 – 2025-12-31
- Annual report 2024Filed via Brønnøysundsregistrene · Period 2024-01-01 – 2024-12-31
- Annual report 2023Filed via Brønnøysundsregistrene · Period 2023-01-01 – 2023-12-31
- Annual report 2022Filed via Brønnøysundsregistrene · Period 2022-01-01 – 2022-12-31
- Annual report 2021Filed via Brønnøysundsregistrene · Period 2021-01-01 – 2021-12-31
| Name | Role | Member since |
|---|---|---|
| Current (1) | ||
JB Chief Executive Officer | Chief Executive Officer | 2013 |
| Name | Role | Member since |
|---|---|---|
| Current (4) | ||
| Chairman | 2021 | |
| Board of Directors | 2021 | |
| Board of Directors | 2021 | |
| Board of Directors | 2021 | |
| Former (1) | ||
| Chairman | 2015 – 2021 | |
No shareholder data available.
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive. Learn more.
No registered parent or subsidiaries
Board members of HUSEBYSKOGEN MEDISINSKE SENTER SA also hold positions in 0 other companies.
| Person | Role here | Other companies |
|---|---|---|
| Jostein Berntsen | Chief Executive Officer | 0 companies |
| Kristine Selmer Solbakken | Chairman | 0 companies |
| Lena Belstad | Board of Directors | 0 companies |
| Philipp Sung-Kun Moon | Chairman | 0 companies |
| Einar Alexander Bøhmer | Board of Directors | 0 companies |
| Naila Saddique | Board of Directors | 0 companies |